| scholarly article | Q13442814 |
| P2093 | author name string | Dan I Andersson | |
| Hervé Nicoloff | |||
| P2860 | cites work | Genomewide overexpression screen for fosfomycin resistance in Escherichia coli: MurA confers clinical resistance at low fitness cost | Q35941216 |
| The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli. | Q36754325 | ||
| Plasmidome-analysis of ESBL-producing escherichia coli using conventional typing and high-throughput sequencing | Q36926956 | ||
| The tetracycline resistome | Q37622770 | ||
| The revival of fosfomycin | Q37938425 | ||
| Phenotypic Resistance to Antibiotics. | Q38793893 | ||
| AcrD of Escherichia coli is an aminoglycoside efflux pump | Q39499577 | ||
| Inactivation of the lipopeptide antibiotic daptomycin by hydrolytic mechanisms | Q39686976 | ||
| Role of outer membrane barrier in efflux-mediated tetracycline resistance of Escherichia coli | Q39835696 | ||
| Sampling the antibiotic resistome | Q40357052 | ||
| Prevention of drug access to bacterial targets: permeability barriers and active efflux | Q40737334 | ||
| Influences of biofilm structure and antibiotic resistance mechanisms on indirect pathogenicity in a model polymicrobial biofilm | Q41487138 | ||
| Importance of extracellular and cell-bound beta-lactamase in mediating resistance of Staphylococcus aureus to mezlocillin | Q41855212 | ||
| Identification of acquired antimicrobial resistance genes | Q41981445 | ||
| Detection of 140 clinically relevant antibiotic-resistance genes in the plasmid metagenome of wastewater treatment plant bacteria showing reduced susceptibility to selected antibiotics | Q43368913 | ||
| TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics | Q45081437 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| The human microbiome harbors a diverse reservoir of antibiotic resistance genes | Q47597533 | ||
| Release of periplasmic enzymes and other physiological effects of beta-lactamase overproduction in Escherichia coli | Q47870483 | ||
| Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection | Q22122301 | ||
| Three decades of beta-lactamase inhibitors | Q24646623 | ||
| The role of beta-lactamase-producing-bacteria in mixed infections | Q24647994 | ||
| One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 | ||
| Functional characterization of the antibiotic resistance reservoir in the human microflora | Q28256703 | ||
| Molecular basis of bacterial outer membrane permeability | Q29617897 | ||
| Complete set of ORF clones of Escherichia coli ASKA library (a complete set of E. coli K-12 ORF archive): unique resources for biological research | Q29619122 | ||
| In vitro efficacy of beta-lactam/beta-lactamase inhibitor combinations against bacteria involved in mixed infections | Q33754341 | ||
| Sheltering effect and indirect pathogenesis of carbapenem-resistant Acinetobacter baumannii in polymicrobial infection | Q33798228 | ||
| Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes | Q33962732 | ||
| Antibiotic resistance in the environment: a link to the clinic? | Q34138597 | ||
| The mechanism of action of fosfomycin (phosphonomycin) | Q34214482 | ||
| Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications | Q34498620 | ||
| Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota | Q34858174 | ||
| Plasmid-mediated high-level resistance to erythromycin in Escherichia coli | Q35649028 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 100-110 | |
| P577 | publication date | 2015-10-14 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Indirect resistance to several classes of antibiotics in cocultures with resistant bacteria expressing antibiotic-modifying or -degrading enzymes | |
| P478 | volume | 71 |
| Q38648472 | A versatile one-step CRISPR-Cas9 based approach to plasmid-curing. |
| Q50043213 | Adaptive benefits from small mutation supplies in an antibiotic resistance enzyme |
| Q64076198 | Antibiotic Resistance Gene Diversity and Virulence Gene Diversity Are Correlated in Human Gut and Environmental Microbiomes |
| Q58108379 | Antibiotics as both friends and foes of the human gut microbiome: The microbial community approach |
| Q93028741 | Bacterial interspecies interactions modulate pH-mediated antibiotic tolerance |
| Q89980591 | Coexistence and cooperation in structured habitats |
| Q36233864 | Collective Resistance in Microbial Communities by Intracellular Antibiotic Deactivation |
| Q55447824 | Community interactions and spatial structure shape selection on antibiotic resistant lineages. |
| Q61034507 | Cooperation, competition and antibiotic resistance in bacterial colonies |
| Q102220377 | Ecology and evolution of antimicrobial resistance in bacterial communities |
| Q39195574 | Environmental and genetic modulation of the phenotypic expression of antibiotic resistance |
| Q60953891 | Mesoporous Silica Materials as Drug Delivery: "The Nightmare" of Bacterial Infection |
| Q92854535 | Mesoporous Silica Nanoparticles for the Treatment of Complex Bone Diseases: Bone Cancer, Bone Infection and Osteoporosis |
| Q59789886 | Migration alters oscillatory dynamics and promotes survival in connected bacterial populations |
| Q36978161 | Oscillatory dynamics in a bacterial cross-protection mutualism |
| Q47119712 | Pseudomonas aeruginosa exoproducts determine antibiotic efficacy against Staphylococcus aureus. |
| Q45950346 | Social behaviour involving drug resistance: the role of initial density, initial frequency and population structure in shaping the effect of antibiotic resistance as a public good. |
| Q91451154 | The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification |
Search more.